Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5532.5000 -15.00 (-0.27%)

NSE Oct 23, 2025 15:21 PM

Volume: 45,813

Alkem Laboratories Ltd.

05 Feb 2022

5532.50

-0.27%

Alkem Labs (HOLD): Strong domestic growth; weak margins

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Robust traction in India formulations (+20% YoY) during Q3, partly offset by a 7% decline in US generic revenue

Alkem Laboratories L.. has an average target of 5463.50 from 2 brokers.